Combination of arsenic exposure, μg/L and HO-1 genotype | Controls n (%) | Patients n (%) | Multivariate-adjusted OR (95% CI) | OR changes for carriers vs. non-carriers of the class S allele, % |
---|---|---|---|---|
Lanyang cohort a | Â | Â | Â | Â |
   ≤ 50, Non-carriers of the class S allele | 8 (3.1) | 6 (2.4) | 1.00 | (Reference) |
   ≤ 50, Carriers of the class S allele | 20 (7.8) | 12 (4.8) | 0.60 (0.15-2.45) | -40.0 |
   50-100, Non-carriers of the class S allele | 21 (8.2) | 24 (9.6) | 1.49 (0.39-5.69) | (Reference) |
   50-100, Carriers of the class S allele | 66 (25.8) | 64 (25.6) | 1.38 (0.40-4.80) | -7.4 |
   100-300, Non-carriers of the class S allele | 19 (7.4) | 20 (8.0) | 1.72 (0.44-6.70) | (Reference) |
   100-300, Carriers of the class S allele | 60 (23.4) | 61 (24.4) | 1.37 (0.39-4.79) | -20.3 |
   > 300, Non-carriers of the class S allele | 17 (6.6) | 22 (8.8) | 1.48 (0.38-5.77) | (Reference) |
   > 300, Carriers of the class S allele | 45 (17.6) | 41 (16.4) | 1.14 (0.32-4.08) | -23.0 |
LMN cohort b | Â | Â | Â | Â |
   ≤ 300, Non-carriers of the class S allele | 13 (7.9) | 2 (1.7) | 1.00 | (Reference) |
   ≤ 300, Carriers of the class S allele | 39 (23.8) | 10 (8.6) | 0.49 (0.07-3.32) | -51.0 |
   300-750, Non-carriers of the class S allele | 22 (13.4) | 20 (17.1) | 1.13 (0.18-7.16) | (Reference) |
   300-750, Carriers of the class S allele | 43 (26.2) | 36 (30.8) | 1.02 (0.17-6.10) | -9.7 |
   > 750, Non-carriers of the class S allele | 10 (6.1) | 14 (12.0) | 4.45 (0.64-30.93) | (Reference) |
   > 750, Carriers of the class S allele | 37 (22.6) | 35 (29.9) | 1.09 (0.18-6.64) | -75.5* |